Why the NSA wants to monitor medical devices

Pacemakers might be the next big thing for foreign intelligence, according to a National Security Agency senior official.

Advertisement

Richard Ledgett, the NSA’s deputy director, said the agency is researching new methods to collect foreign intelligence, including the possibility of using internet-connected biomedical devices.

“We’re looking at it sort of theoretically from a research point of view right now,” said Mr. Ledgett at a conference on military technology in Washington, D.C., on Friday.

While he acknowledges easier ways to keep track of terrorists overseas, Mr. Ledgett believes the devices could provide a new source of information for the NSA’s massive collection of data — “a niche kind of thing…a tool in the toolbox,” he said.

Mr. Ledgett acknowledges the NSA does not have the right to mandate security standards for device manufacturers in regards to new devices.

However, the NSA, which prohibits employees from having cell phones in the building, cannot ignore the potential for outsiders to hack into the agency through these biomedical devices. While no NSA employee has needed an internet-connected biomedical device yet, it will be a concern for the agency when someone does.

More articles on supply chain:

FDA urges drug companies to explore more unproven approaches in the cancer drug market
New treatment can stop multiple sclerosis in its tracks
FDA draft guidance encourages medical device makers to share data with patients

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.